VTGN
Price
$4.04
Change
+$0.03 (+0.75%)
Updated
Oct 15, 12:24 PM (EDT)
Capitalization
123.03M
Intraday Buy/Sell Signals
XLO
Price
$0.77
Change
+$0.01 (+1.32%)
Updated
Oct 15, 04:04 PM (EDT)
Capitalization
39.34M
22 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

VTGN vs XLO

Header iconVTGN vs XLO Comparison
Open Charts VTGN vs XLOBanner chart's image
VistaGen Therapeutics
Price$4.04
Change+$0.03 (+0.75%)
Volume$400
Capitalization123.03M
Xilio Therapeutics
Price$0.77
Change+$0.01 (+1.32%)
Volume$400
Capitalization39.34M
VTGN vs XLO Comparison Chart in %
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
VTGN vs. XLO commentary
Oct 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VTGN is a Hold and XLO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 15, 2025
Stock price -- (VTGN: $4.01 vs. XLO: $0.76)
Brand notoriety: VTGN and XLO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: VTGN: 104% vs. XLO: 52%
Market capitalization -- VTGN: $123.03M vs. XLO: $39.34M
VTGN [@Biotechnology] is valued at $123.03M. XLO’s [@Biotechnology] market capitalization is $39.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

VTGN’s FA Score shows that 0 FA rating(s) are green whileXLO’s FA Score has 0 green FA rating(s).

  • VTGN’s FA Score: 0 green, 5 red.
  • XLO’s FA Score: 0 green, 5 red.
According to our system of comparison, VTGN is a better buy in the long-term than XLO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VTGN’s TA Score shows that 5 TA indicator(s) are bullish while XLO’s TA Score has 4 bullish TA indicator(s).

  • VTGN’s TA Score: 5 bullish, 4 bearish.
  • XLO’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, VTGN is a better buy in the short-term than XLO.

Price Growth

VTGN (@Biotechnology) experienced а +1.26% price change this week, while XLO (@Biotechnology) price change was -7.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.75%. For the same industry, the average monthly price growth was +17.87%, and the average quarterly price growth was +82.92%.

Reported Earning Dates

XLO is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+0.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTGN($123M) has a higher market cap than XLO($39.3M). VTGN YTD gains are higher at: 35.932 vs. XLO (-20.524). XLO has higher annual earnings (EBITDA): -55.02M vs. VTGN (-58.99M). XLO has more cash in the bank: 122M vs. VTGN (63.2M). VTGN has less debt than XLO: VTGN (2.36M) vs XLO (7.57M). XLO has higher revenues than VTGN: XLO (15M) vs VTGN (646K).
VTGNXLOVTGN / XLO
Capitalization123M39.3M313%
EBITDA-58.99M-55.02M107%
Gain YTD35.932-20.524-175%
P/E RatioN/AN/A-
Revenue646K15M4%
Total Cash63.2M122M52%
Total Debt2.36M7.57M31%
FUNDAMENTALS RATINGS
VTGN: Fundamental Ratings
VTGN
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
VTGNXLO
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 10 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PWP19.720.70
+3.68%
Perella Weinberg Partners
COF214.206.59
+3.17%
Capital One Financial
TTSH6.260.19
+3.13%
Tile Shop Holdings
NXST197.913.45
+1.77%
Nexstar Media Group
BAFN9.330.08
+0.86%
BayFirst Financial Corp

VTGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTGN has been loosely correlated with COGT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if VTGN jumps, then COGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTGN
1D Price
Change %
VTGN100%
+2.56%
COGT - VTGN
43%
Loosely correlated
-4.72%
IMNM - VTGN
42%
Loosely correlated
-1.26%
SYRE - VTGN
42%
Loosely correlated
+11.02%
SRRK - VTGN
40%
Loosely correlated
-6.93%
IPSC - VTGN
39%
Loosely correlated
+1.84%
More